Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The challenge of target sequence specificity in C-->U RNA editing.

Literature DB >> 11827986

The challenge of target sequence specificity in C-->U RNA editing.

Nicholas O Davidson¹.

Abstract

Mesh：

Substances：
Apolipoproteins B
RNA

Year: 2002 PMID： 11827986 PMCID： PMC150866 DOI： 10.1172/JCI14979

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

31 in total

1. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene.

Authors: J O Henderson; V Blanc; N O Davidson
Journal: Biochim Biophys Acta Date: 2001-11-11

2. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.

Authors: Debnath Mukhopadhyay; Shrikant Anant; Robert M Lee; Susan Kennedy; David Viskochil; Nicholas O Davidson
Journal: Am J Hum Genet Date: 2001-11-27 Impact factor: 11.025

3. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.

Authors: S Anant; D Mukhopadhyay; V Sankaranand; S Kennedy; J O Henderson; N O Davidson
Journal: Am J Physiol Cell Physiol Date: 2001-12 Impact factor: 4.249

4. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.

Authors: V Blanc; J O Henderson; S Kennedy; N O Davidson
Journal: J Biol Chem Date: 2001-09-24 Impact factor: 5.157

5. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.

Authors: S Anant; J O Henderson; D Mukhopadhyay; N Navaratnam; S Kennedy; J Min; N O Davidson
Journal: J Biol Chem Date: 2001-09-27 Impact factor: 5.157

6. Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins.

Authors: S G Harris; I Sabio; E Mayer; M F Steinberg; J W Backus; J D Sparks; C E Sparks; H C Smith
Journal: J Biol Chem Date: 1993-04-05 Impact factor: 5.157

7. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.

Authors: S Yamanaka; M E Balestra; L D Ferrell; J Fan; K S Arnold; S Taylor; J M Taylor; T L Innerarity
Journal: Proc Natl Acad Sci U S A Date: 1995-08-29 Impact factor: 11.205

8. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.

Authors: G R Skuse; A J Cappione; M Sowden; L J Metheny; H C Smith
Journal: Nucleic Acids Res Date: 1996-02-01 Impact factor: 16.971

9. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.

Authors: M Sowden; J K Hamm; S Spinelli; H C Smith
Journal: RNA Date: 1996-03 Impact factor: 4.942

10. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.

Authors: A J MacGinnitie; S Anant; N O Davidson
Journal: J Biol Chem Date: 1995-06-16 Impact factor: 5.157

3 in total